FDA approves OSPREY study to evaluate aura6000 System to treat OSALivaNova has received approval from the FDA to proceed with its investigational device exemption (IDE) clinical study, ‘Treating...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure5 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity5 days ago